Lifeboat Foundation

Two of SA’s most promising female technology entrepreneurs have this year raised millions from astute local and international investors for their global-impact businesses in healthcare and space.

Presagen, co-founded by Dr Michelle Perugini, raised a total of $4.5 million from Jungle Capital group in Australia and US private investor 3Lines Venture Capital, with the SA Government also pitching in.

The funding will help commercialise its Life Whisperer artificial intelligence (AI) platform. Life Whisperer uses AI to identify healthy embryos in in-vitro fertilisation (IVF) with the aim of improving pregnancy outcomes for infertile couples globally.

Every single member of the UN doubled-down today on a commitment to provide universal health coverage to their citizens. The fact that the US will be among them is perhaps evidence of how disconnected these declarations can be from actual domestic political agendas.

Yet the issue is important, and it shows just how out of line the US approach to health care coverage is compared to the rest of the world. Only about half the world’s population has access to the kind of affordable health care services that don’t require crippling out-of-pocket costs. Most of those people are in mid- and low-income countries. Or they are in the wealthiest country on Earth: the US.

Bringing universal health care to everyone is one of the “sustainable development goals,” the ambitious to-do list for UN member countries to complete by 2030. For the UN, universal health care means, “financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all.”

Rejuvenation Biotechnology: on track to be the biggest industry ever.

Dr Aubrey de Grey, CSO at the SENS Research Foundation speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Aubrey discusses Rejuvenation biotechnology and how it’s on track to become the biggest industry ever.

Continue reading “Dr Aubrey de Grey | Investing in the Age of Longevity 2019” »

Gene therapies to reverse immunosenescence and atherosclerosis.

CEO of Repair Biotechnologies speaking at Master Investor’s Investing in the Age of Longevity 2019 event. Reason discusses gene therapies to reverse immunosenescence and atherosclerosis.

Continue reading “Reason | Investing in the Age of Longevity 2019” »

The national artificial intelligence strategy, which was unveiled in November, will focus on five key sectors — transport and logistics, smart cities and estates, safety and security, healthcare, and education.

Read the full story: https://www.straitstimes.com/singapore/tapping-ai-to-deliver…ect-issues

Continue reading “Singapore’s human-centric artificial intelligence strategy | The Straits Times” »

https://www.youtube.com/watch?v=J2G-Sq7iOuM

Hollie Fraser, founder of Books On The Move, worldwide book sharing movement, creative director and ideaXme literature, reading and writing ambassador interviews Matthew Newman, 2019 best Kindle book author.

Continue reading “How to Start at The Finish Line: Cancer Survivor” »

Germany’s prized industrial robotics and automation sector is expecting a drop in sales this year for the first time since the global financial crisis, an industry body said on Friday.

The Mechanical Engineering Industry Association (VDMA) is expecting sales to fall by five percent to 14.3 billion euros ($15.8 billion) this year.

This would be the first drop since the 32-percent plunge seen in 2009 in the wake of the crisis.

Haven’t heard from Fossel in awhile. This is long but well indexed in the notes.

My mission is to drastically improve your life by helping you break bad habits, build and keep new healthy habits to make you the best version of yourself.

Continue reading “Brent Nally interviews Dr. Michael Fossel about Telocyte and telomerase gene therapy on 11/16/2019” »

“Demonstrate That Top Financial and Tech Corporations Are Committed to Longevity”

This week two Landmark International Longevity Summits in London attracted the attention of scientists, government officials, major financial corporations, insurance companies, investment banks, and technology companies from around the world. The Landmark AI for Longevity Summit and the First International Longevity Policy and Governance Summit at King’s College London are expected to become the world-leading forums for the Longevity Industry.